During the past decade, SFGH Women's Options Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "SFGH Women's Options Center" #1 collaborator was "FPA Women's Health" with 1 trials as a collaborator, "Oregon Health and Science University" with 1 trials as a collaborator and "Society of Family Planning" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "SFGH Women's Options Center" are "Abortion" (3 trials) and "Hemorrhage" (1 trials). Many other conditions were trialed in "SFGH Women's Options Center" in a lesser frequency.

Most popular intervention types in "SFGH Women's Options Center" are "Behavioral" (2 trials), "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Delayed initiation of OCPs" (1 trials), "Digoxin" (1 trials), "Immediate initiation of OCPs" (1 trials), "Methergine" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "SFGH Women's Options Center" are 4 trials for "Female" genders.

Currently, there are NaN active trials in "SFGH Women's Options Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in SFGH Women's Options Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SFGH Women's Options Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".